Suchergebnisse - "Pinato, David J"

PubPharm (285)

61

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma : An international observational study

enthalten in: Liver International | 2023

von Talbot, T. | D'Alessio, A. | Pinter, M. | +33

62

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

enthalten in: Clinical genitourinary cancer | 2022

von Talukder, R. | Makrakis, D. | Lin, G. | +51

63

Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer

enthalten in: Cancer treatment reviews | 2022

von Schettini, F. | Venturini, S. | Giuliano, M. | +27

64

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

enthalten in: Journal of translational medicine | 2022

von Zhang, Z. | Rafei-Shamsabadi, D. | Lehr, S. | +7

65

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

enthalten in: Journal of translational medicine | 2022

von Zhang, Z. | Rafei-Shamsabadi, D. | Lehr, S. | +7

66

Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity

enthalten in: Journal of translational medicine | 2022

von Zhang, Z. | Rafei-Shamsabadi, D. | Lehr, S. | +7

67

Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer

enthalten in: Gastroenterology | 2022

von D'Alessio, A. | Pinato, D.

CommentOn: Nat Med. 2022 Aug;28(8):1599-1611. - PMID 35739268

68

Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer : a joint analysis of OnCovid and ESMO-CoCARE registries

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Dettorre, G. | Dafni, U. | +40

69

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

enthalten in: Cancers | 2022

von Wu, Y. | Fulgenzi, C. | D'Alessio, A. | +32

70

Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer

enthalten in: British journal of cancer | 2022

von Cortellini, A. | Aguilar-Company, J. | Salazar, R. | +12